The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a quantitative PD-L1 assay using laser capture microdissection (LCM)-based reverse phase protein microarray (RPPA) workflow: Implications for precision medicine.
 
Mariaelena Pierobon
Stock and Other Ownership Interests - Theranostics Health
Consulting or Advisory Role - Perthera
Patents, Royalties, Other Intellectual Property - Theranostic Health/Avant
 
Elisa Baldelli
No Relationships to Disclose
 
K. Alex Hodge
No Relationships to Disclose
 
Maria Isabella Sereni
No Relationships to Disclose
 
Vienna Ludovini
No Relationships to Disclose
 
Guido Bellezza
No Relationships to Disclose
 
Lucio Crino
No Relationships to Disclose
 
Lance A. Liotta
Stock and Other Ownership Interests - Ceres Nanosciences; Theranostics Health
Patents, Royalties, Other Intellectual Property - Theranostics Health
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Ceres Nanosciences; D3D Inc.; Perthera
Consulting or Advisory Role - Ceres Nanosciences; Perthera; Zymeworks
Research Funding - Ceres Nanosciences (Inst); GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera